Cell Culture Engineering: 101 (Advances in Biochemical Engineering/Biotechnology, 101) - Image 1

£210.78

Springer Cell Culture Engineering: 101 (Advances in Biochemical Engineering/Biotechnology, 101)

Name: Cell Culture Engineering: 101 (Advances in Biochemical Engineering/Biotechnology, 101)
Brand: Springer
Price: 210.78 GBP
Availability: InStock

Physiology

About as cheap as it gets. The only time it was cheaper was 1 year ago.

£211 today · all-time low £201 (May 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 583 days • 583 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 583 days • 8 price levels

Days at Price

Current Price

Price Analysis

Most common price: £201 (388 days, 66.6%)

Price range: £201 - £250

Price levels: 8 different prices over 583 days

Description

Since the introduction of recombinant human growth hormone and insulin a quarter century ago, protein therapeutics has greatly broadened the ho- zon of health care. Many patients suffering with life-threatening diseases or chronic dysfunctions, which were medically untreatable not long ago, can attest to the wonder these drugs have achieved. Although the ?rst generation of p- tein therapeutics was produced in recombinant Escherichia coli, most recent products use mammalian cells as production hosts. Not long after the ?rst p- duction of recombinant proteins in E. coli, it was realized that the complex tasks of most post-translational modi?cations on proteins could only be ef?ciently carried out in mammalian cells. In the 1990s, we witnessed a rapid expansion of mammalian-cell-derived protein therapeutics, chie?y antibodies. In fact, it has been nearly a decade since the market value of mammalian-cell-derived protein therapeutics surpassed that of those produced from E. coli. A common characteristic of recent antibody products is the relatively large dose required for effective therapy, demanding larger quantities for the treatment of a given disease. This, coupled with the broadening repertoire of protein drugs, has rapidly expanded the quantity needed for clinical applications. The increasing demand for protein therapeutics has not been met exclusively by construction of new manufacturing plants and increasing total volume capacity. More - portantly the productivity of cell culture processes has been driven upward by an order of magnitude in the past decade.

Product Specifications

Brand: Springer
Format: Paperback
ASIN: 3642070515
Category: Books > Subjects > Science, Nature & Maths > Biological Sciences > Animal Sciences > Physiology
Domain: Amazon UK
Release Date: 18 November 2010
Listed Since: 20 September 2010

Barcode

No barcode data available

Springer Cell Culture Engineering: 101 (Advances in Biochemical Engineering/Biotechnology, 101)

About as cheap as it gets. The only time it was cheaper was 1 year ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Animal Cell Technology: Products from Cells, Cells as Products: Proceedings of the 16th ESACT Meeting April 25–29, 1999, Lugano, Switzerland

Immunocytochemical Methods and Protocols: 115 (Methods in Molecular Biology, 115)

Cell and Tissue Reaction Engineering (Principles and Practice)

Animal Cell Biotechnology: Methods and Protocols: 2095 (Methods in Molecular Biology, 2095)

Cell and Tissue Reaction Engineering (Principles and Practice)

Animal Cell Technology: From Vaccines to Genetic Medicine

Animal Cell Biotechnology: Methods and Protocols: 1104 (Methods in Molecular Biology, 1104)

Medicines from Animal Cell Culture

Antibody Engineering: Methods and Protocols: 248 (Methods in Molecular Biology, 248)

Safety in Cell and Tissue Culture

Mammalian Cell Cultures for Biologics Manufacturing: 139 (Advances in Biochemical Engineering/Biotechnology, 139)

Animal Cell Technology

Biopharmaceutical Manufacturing: Progress, Trends and Challenges: 11 (Cell Engineering, 11)

Animal Cell Culture: 9 (Cell Engineering, 9)

Animal Cell Culture: 9 (Cell Engineering, 9)

Human Monoclonal Antibodies: Methods and Protocols: 1060 (Methods in Molecular Biology, 1060)

Biopharmaceuticals: Challenges and Opportunities

Producing Biomolecular Substances with Fermenters, Bioreactors, and Biomolecular Synthesizers

Humana Antibody Engineering: Methods and Protocols 1827

Antibodies: Volume 2: Novel Technologies and Therapeutic Use

Antibody Engineering Volume 2

Cell Culture and Upstream Processing

ARTIFICIAL CELLS: BIOTECHNOLOGY, NANOMEDICINE, REGENERATIVE MEDICINE, BLOOD SUBSTITUTES, BIOENCAPSULATION, AND CELL/STEM CELL THERAPY: 1 (Regenerative Medicine, Artificial Cells And Nanomedicine)

Advances In Pharmaceutical Cell Therapy: Principles Of Cell-Based Biopharmaceuticals